Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -5.80 (-5.32%)
Bid:
103.00
Ask:
104.20
Spread: 1.20 (1.165%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Disposal

21 Jul 2008 07:00

RNS Number : 4727Z
Yule Catto & Co PLC
21 July 2008
 



Yule Catto & Co. plc

Sale of ultramarine pigment business

Yule Catto is an international producer of speciality chemicals, supplied to global customers for use in a wide range of industries including pharmaceuticals, FMCG, paints and adhesives

Yule Catto & Co plc ("Yule Catto" or the "Company") is pleased to announce that it has exchanged conditional contracts with Rockwood Specialities Group Inc ("Rockwood") for the sale of the entire issued share capital of Holliday Pigments SA, Holliday Pigments International SA, Holliday France SA and Holliday Chemical Espana SA for a consideration of €46 million. The consideration will be paid in full in cash at completion.

The completion of the sale is conditional on regulatory clearances in Germany and Austria, which are expected to be obtained by the first week of August.

The proceeds of the sale received by Yule Catto will be used to reduce the Company's borrowings.

Holliday Pigments SA and Holliday Pigments International SA manufacture and supply ultramarine pigments. Holliday France SA and Holliday Chemical Espana SA are trading companies operating in the French and Spanish markets respectively. In the 12 months to 31 December 2007, the combined companies had, at historic exchange rates, an operating profit of £3.2 million and gross assets of £17.3 million.

Glyn Jagger will continue as Managing Director of the companies.

Adrian Whitfield, Chief Executive, commented:

"This sale is in line with our stated strategy of realising increased shareholder value from the businesses within Impact Chemicals. I strongly believe that this represents a good deal for our shareholders and will take total realisations from all Impact Chemical disposals this year to some £50 million. "

21 July 2008 

Enquiries:

Yule Catto & Co. plc
Tel: 01279 442791
Adrian Whitfield, Chief Executive 
 
David Blackwood, Finance Director
 
 
 
College Hill
Tel: 020 7457 2020
Gareth David
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISIIFEEDVILFIT
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.